Rutherford Health was a private oncology provider founded by Mike Moran and Karol Sikora in 2015, with investment from Neil Woodford and the Wales Life Sciences Investment Fund, to develop proton therapy facilities in the United Kingdom and elsewhere.
[2][3] According to major shareholder Schroders UK Public Private Trust, the company had pursued a "flawed expansion strategy ... from 2015 to 2019" leading to "a high and unsustainable cash burn".
[4][5][6] Rutherford Health ran proton therapy centres in Newport, Wales, Bedlington, Northumberland, Liverpool and Reading, Berkshire.
In June 2020, Rutherford Health partnered with Panthera Biopartners to set up a network of clinical trial sites.
[22][23] In September 2021 Michael Richards opened the first community diagnostic centre in England, on the outskirts of Taunton, to be operated by Rutherford Health in partnership with Somerset NHS Foundation Trust.